Table 1.
HA antibody levels (EU) and hemagglutination inhibition (HI) response in mice
G.M. IgG anti-HA | No. with | |||
---|---|---|---|---|
Immunogen | Dosage | EU (25-75 centiles) | HI ≥40 | |
rHA-alum | 5 μg × 2 | 14.4 | (10.6-21.2) | 8/10 |
rHA-alum | 5 μg × 3 | 177.8 | (112-286) | 8/10 |
rHA-formalin | 5 μg × 2 | 26.6 | (22.2-41.3) | 8/10 |
rHA-formalin | 5 μg × 3 | 40.1 | (33.5-52.2 | 10/10 |
rHA-formalin-alum | 5 μg × 2 | 14.4 | (10.9-20.1) | 3/10 |
rHA-formalin-alum | 5 μg × 3 | 212.7 | (119.3-270.8) | 10/10 |
rHA-alum-formalin | 5 μg × 2 | 3.2 | (1.7-9.15) | 5/10 |
rHA-alum-formalin | 5 μg × 3 | 10.0 | (7.95-17.1) | 9/10 |
rHA | 5 μg × 3 | 61.5 | (24.7-249) | 9/9 |
rHA-alum | 15 μg × 3 | 449.4 | (224-757) | 10/10 |
PBS (control) | 0.01 | (0.005-0.005) | 0/10 |
Mice, 5-6 week old, were injected s.c. 2 or 3 times 2 weeks apart and bled 1 week after the last injection.
14.4 vs 177.8, 212.7 p<0.0001; 26.6 vs 40.1 p Not Significant (NS);
3.2 vs 10 p NS; 177.8 vs 40.1, 10 p<0.0001; 177.8 vs 212.7 p NS;
449.4 vs 177.8, 212.7 p<0.01